Gansubin, Juanito G.
HRN: 15-98-89 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2025
CIPROFLOXACIN 500MG (TAB)
11/10/2025
11/16/2025
PO
500mg
BID
AGE W/ Moderate Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes